GlaxoSmithKline reported 466.4B in Stock for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Alcon AG ALC:SW 1.9B 52.44M
Almirall ALM:SM 120.71M 706K
Amgen AMGN:US $ 4554M 143M
Bayer BAYN:GR € 11371M 502M
Biogen BIIB:US $ 1294.2M 78.8M
Bristol Myers Squibb BMY:US $ 2142M 38M
Eli Lilly And LLY:US $ 3899.4M 6.4M
Fresenius FRE:GR € 4697M 274M
Gilead Sciences GILD:US $ 2587M 88M
GlaxoSmithKline GSK:LN 466400M 133900M
Hikma Pharmaceutical HIK:LN 62.93B 10.96B
Merck MRK:GR € 4474M 331M
Novartis NOVN:VX SF 6880M 117M
Orion ORNBV:FH € 316.8M 42M
Recordati REC:IM € 409.79M 153.3M
Regeneron Pharmaceuticals REGN:US $ 2218.5M 227M